161 related articles for article (PubMed ID: 12853200)
1. Effect on dyspnoea and hypoxaemia of inhaled N(G)-nitro-L-arginine methyl ester in hepatopulmonary syndrome.
Brussino L; Bucca C; Morello M; Scappaticci E; Mauro M; Rolla G
Lancet; 2003 Jul; 362(9377):43-4. PubMed ID: 12853200
[TBL] [Abstract][Full Text] [Related]
2. Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome.
Gómez FP; Barberà JA; Roca J; Burgos F; Gistau C; Rodríguez-Roisin R
Hepatology; 2006 May; 43(5):1084-91. PubMed ID: 16628648
[TBL] [Abstract][Full Text] [Related]
3. Inhaled iloprost for hepatopulmonary syndrome: improvement of hypoxemia.
Krug S; Seyfarth HJ; Hagendorff A; Wirtz H
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1140-3. PubMed ID: 17998841
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment with N-nitro-L-arginine methyl ester improved oxygenation after inhalation of nitric oxide in newborn piglets with Escherichia coli pneumonia and sepsis.
Chang YS; Kang S; Ko SY; Park WS
J Korean Med Sci; 2006 Dec; 21(6):965-72. PubMed ID: 17179670
[TBL] [Abstract][Full Text] [Related]
5. Breathlessness in liver disease: A case of hepatopulmonary syndrome .
Porther R; Ross G; Nagasayi S
Clin Med (Lond); 2019 May; 19(3):250-251. PubMed ID: 31092521
[TBL] [Abstract][Full Text] [Related]
6. [Hepatopulmonary syndrome in liver cirrhosis].
Culafić Dj; Perisić M; Rebić P
Srp Arh Celok Lek; 2000; 128(7-8):271-5. PubMed ID: 11089435
[TBL] [Abstract][Full Text] [Related]
7. Regulation of heme oxygenase-1 by nitric oxide during hepatopulmonary syndrome.
Carter EP; Hartsfield CL; Miyazono M; Jakkula M; Morris KG; McMurtry IF
Am J Physiol Lung Cell Mol Physiol; 2002 Aug; 283(2):L346-53. PubMed ID: 12114196
[TBL] [Abstract][Full Text] [Related]
8. Peripheral or central administration of nitric oxide synthase inhibitor affects feeding behavior in chicks.
Khan MS; Tachibana T; Hasebe Y; Masuda N; Ueda H
Comp Biochem Physiol A Mol Integr Physiol; 2007 Oct; 148(2):458-62. PubMed ID: 17618151
[TBL] [Abstract][Full Text] [Related]
9. [Hepatopulmonary syndrome].
Thevenot T; Pastor CM; Cervoni JP; Jacquelinet C; Nguyen-Khac E; Richou C; Heyd B; Vanlemmens C; Mantion G; Di Martino V; Cadranel J
Gastroenterol Clin Biol; 2009; 33(6-7):565-79. PubMed ID: 19481392
[TBL] [Abstract][Full Text] [Related]
10. Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses.
López RM; Pérez T; Castillo C; Castillo MC; Castillo EF
Fundam Clin Pharmacol; 2011 Jun; 25(3):333-42. PubMed ID: 20608990
[TBL] [Abstract][Full Text] [Related]
11. Effect of nitric oxide synthase inhibitor on optic nerve head circulation in conscious rabbits.
Sugiyama T; Oku H; Ikari S; Ikeda T
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1149-52. PubMed ID: 10752953
[TBL] [Abstract][Full Text] [Related]
12. N(G)-nitro-L-arginine and its methyl ester inhibit brain synthesis of kynurenic acid possibly via nitric oxide-independent mechanism.
Luchowski P; Kocki T; Urbańska EM
Pol J Pharmacol; 2001; 53(6):597-604. PubMed ID: 11985333
[TBL] [Abstract][Full Text] [Related]
13. Effect of NG-nitro-L-arginine methyl ester, the nitric oxide synthase inhibitor, on duodenal alkaline secretion and mepirizole-induced duodenal lesions in rats.
Takeuchi K; Takehara K; Kato S
J Clin Gastroenterol; 1995; 21 Suppl 1():S66-72. PubMed ID: 8774993
[TBL] [Abstract][Full Text] [Related]
14. Deleterious effect of nitric oxide inhibition in chronic hepatopulmonary syndrome.
Almeida JA; Riordan SM; Liu J; Galhenage S; Kim R; Bihari D; Wegner EA; Cranney GB; Thomas PS
Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):341-6. PubMed ID: 17353701
[TBL] [Abstract][Full Text] [Related]
15. [Hepatopulmonary syndrome. A consideration in patients with liver disease accompanied by dyspnoea and hypoxaemia].
van Hirtum PV; Bootsma GP; de Man RA; van Deursen CTBM; Bonta PI; de Kruif MD
Ned Tijdschr Geneeskd; 2017; 161():D1387. PubMed ID: 28589869
[TBL] [Abstract][Full Text] [Related]
16. Dyspnoea, clubbing, cirrhosis, and bubbles in both sides of the heart suggests hepatopulmonary syndrome.
Low ESL; Patwala K; Apostolov R
Lancet; 2019 Aug; 394(10197):510. PubMed ID: 31402029
[No Abstract] [Full Text] [Related]
17. Cerebral metabolic recovery from deep hypothermic circulatory arrest after treatment with arginine and nitro-arginine methyl ester.
Hiramatsu T; Jonas RA; Miura T; duPlessis A; Tanji M; Forbess JM; Holtzman D
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):698-707. PubMed ID: 8800158
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
Machelska H; Labuz D; Przewłocki R; Przewłocka B
J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
[TBL] [Abstract][Full Text] [Related]
19. Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats.
Nunes H; Lebrec D; Mazmanian M; Capron F; Heller J; Tazi KA; Zerbib E; Dulmet E; Moreau R; Dinh-Xuan AT; Simonneau G; Hervé P
Am J Respir Crit Care Med; 2001 Sep; 164(5):879-85. PubMed ID: 11549549
[TBL] [Abstract][Full Text] [Related]
20. Methylene blue improves the hepatopulmonary syndrome.
Schenk P; Madl C; Rezaie-Majd S; Lehr S; Müller C
Ann Intern Med; 2000 Nov; 133(9):701-6. PubMed ID: 11074903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
